NAMI
UTHR icon

Nomura Asset Management International’s United Therapeutics UTHR Stock Holding History

Nomura Asset Management International’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Hold
5,600
– – ﹤0.01% 963
2026
Q1 		$3.32M Hold
5,600
– – 0.01% 862
2025
Q4 		$2.73M Buy
+5,600
New +$2.61M ﹤0.01% 934

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Nomura Asset Management International's UTHR Position: Q2 2026 in Review

Nomura Asset Management International held its United Therapeutics (UTHR) position steady in Q2 2026 at 5,600 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Nomura Asset Management International first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.32M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Nomura Asset Management International held 5,600 shares of United Therapeutics worth $3.03M as of Q2 2026.
  • Nomura Asset Management International left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #963 holding.
  • Nomura Asset Management International first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's United Therapeutics position peaked at $3.32M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.